Evogene Reports First Quarter of 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Evogene (EVGN) Reports Q1 Loss of $0.15
May 28, 2019 7:03 AM EDTEvogene (NASDAQ: EVGN) reported Q1 EPS of ($0.15), versus ($0.21) reported last year. Revenue for the quarter came in at $348 thousand versus the consensus estimate of $1.9 million.
Ofer Haviv, Evogene\'s President and CEO, stated: "In 2019 we have completed the transition, as planned, to our new corporate structure consisting of Evogene, the company, as a technology hub for multiple divisions and subsidiaries in different life-science markets,... More



